The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure. [electronic resource]
Producer: 20140731Description: 1262-72 p. digitalISSN:- 1940-6215
- Adenocarcinoma -- drug therapy
- Adrenergic alpha-2 Receptor Agonists -- pharmacology
- Animals
- Antidepressive Agents, Tricyclic -- pharmacology
- Apoptosis
- Breast Neoplasms -- drug therapy
- Cell Proliferation
- Collagen -- chemistry
- Cytokines -- metabolism
- Desipramine -- pharmacology
- Dexmedetomidine -- pharmacology
- Disease Progression
- Female
- Humans
- Image Processing, Computer-Assisted
- Immunoenzyme Techniques
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Microscopy, Fluorescence, Multiphoton
- Norepinephrine -- metabolism
- Receptors, Adrenergic, alpha-2 -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.